’·è‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È •ªŽq–ò—Šw•ª–ì
publication
HOME
‹³Žöˆ¥ŽA
ƒƒ“ƒo[Ð‰î
Œ¤‹†ŠT—vEŒ¤‹†‚Ö‚Ì—U‚¢
Œ¤‹†‹ÆÑ
‹³ˆçŠˆ“®
Šw‰ïEŒ¤‹†‰ïEƒƒfƒBƒAŒfÚ
sŽ–
•åW
ƒAƒNƒZƒX
 
’·è‘åŠwd“_‰Û‘èu’ɂݍŽ•ž‚̍‘Û“IŒ¤‹†‹³ˆç‹’“_‚ÌŒ`¬v
 
 
 
Œ¤‹†‹ÆÑ
ƒz[ƒ€>Œ¤‹†‹ÆÑ>‰¢•¶Œ´’˜˜_•¶i‚Q‚O‚P‚U”Nj

‰¢•¶Œ´’˜˜_•¶@i‚Q‚O‚P‚U”Nj

1.       Maeda S,Sasaki K,Halder SK,Fujita W,Ueda H:Neuroprotective DAMPs member prothymosin alpha has additional beneficial actions against cerebral ischemia-induced vascular damages. J Pharmacol Sci . 132:100-104,2016

2.       Tsukahara R,Ueda H:Myelin-related gene silencing mediated by LPA1 - Rho/ROCK signaling is correlated to acetylation of NFƒÈB in S16 Schwann cells. J Pharmacol SciD 132F162-165,2016

3.       Huy NT, Chi PL, Nagai J, Dang TN, Mbanefo EC, Ahmed AM, Long NP, Thoa LT, Hung LP, Titouna A, Kamei K, Ueda H, Hirayama K: High-throughput screening and prediction models building for novel hemozoin inhibitors using physicochemical properties. AAC. 61(2),2017.2

 
 
’·è‘åŠw
 
Copyright